Clal Insurance Enterprises Holdings LTD Johnson & Johnson Transaction History

Clal Insurance Enterprises Holdings LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$140.38 - $153.83 $421,140 - $461,490	-3,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $128,810 - $155,510	-1,000 Reduced 25.0%	3,000 $422,000
Q1 2020 Aug 14, 2020	BUY	$111.14 - $153.99 $386,100 - $534,961	3,474 Added 660.46%	4,000 $526,000
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $6,334 - $8,777	-57 Reduced 9.78%	526 $68,000
Q4 2019 Feb 13, 2020	BUY	$127.5 - $146.44 $74,332 - $85,374	583 New	583 $85,000

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Clal Insurance Enterprises Holdings LTD, based on Form 13F filings with the SEC.

Stay updated on Clal Insurance Enterprises Holdings LTD with notifications on news.